Related Experiment Video
Updated: Aug 9, 2026

10:35
Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
Published on: May 31, 2020
Recent advances in tropical diseases research
Summary
The Special Programme for Research and Training in Tropical Diseases advances new tools and strengthens research in endemic countries. This initiative targets six major tropical diseases, including malaria and leprosy, with promising early scientific results.
Area of Science:
- Tropical medicine
- Infectious disease research
- Global health initiatives
Background:
- Renewed global efforts focus on developing novel tools to combat parasitic and infectious tropical diseases.
- The World Health Assembly resolution spurred the creation of the Special Programme for Research and Training in Tropical Diseases (TDR).
Purpose of the Study:
- To develop new and improved tools for controlling six key tropical diseases.
- To enhance the research capabilities of tropical countries through institutional strengthening and training.
Main Methods:
- Collaborative network involving the World Health Organization (WHO), UNDP, and the World Bank.
- Focus on research and development for chemotherapy, vaccines, and diagnostic tools.
- Support for national institutions and scientists in endemic countries.
Main Results:
- Progress in chemotherapy for malaria, schistosomiasis, and filariasis.
- Development and testing of a leprosy vaccine and advancements in malaria vaccine knowledge.
- Creation of simple, accurate diagnostic field tests for malaria, leprosy, and African trypanosomiasis.
- Significant increase in institutional strengthening and training support for developing nations.
Conclusions:
- The program has achieved early scientific successes in developing control tools and diagnostic methods.
- Substantial progress has been made in building research capacity within tropical countries.
- Collaboration with international agencies and the pharmaceutical industry is crucial for program success.
Related Concept Videos
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

